Artificial Intelligence Evaluation of Stool Quality Guides Management of Hepatic Encephalopathy Using a Smartphone App

Lactulose-based hepatic encephalopathy treatment requires bowel movements/day titration, which is improved with Bristol stool scale (BSS) incorporation. Dieta app evaluates artificial intelligence (AI)-based BSS (AI-BSS) with stool images. Initially, controls (N = 13) and cirrhosis patients on lactu...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 119; no. 5; pp. 977 - 981
Main Authors Fagan, Andrew, Gallagher, Mary Leslie, Mousel, Travis, Davis, Brian C., Fuchs, Michael, Puri, Puneet, Anstey, Jacob, Tiede, David, Simonetto, Douglas A., Kraus, Asaf, Bajaj, Jasmohan S.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Wolters Kluwer 01.05.2024
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subjects
Adult
Aged
Artificial Intelligence
Communication
Feces - chemistry
Female
Gastrointestinal Agents - administration & dosage
Gastrointestinal Agents - therapeutic use
Hepatic Encephalopathy - therapy
Hepatology
Humans
Irritable bowel syndrome
Lactulose - administration & dosage
Lactulose - therapeutic use
Liver cirrhosis
Liver Cirrhosis - complications
Liver diseases
Male
Middle Aged
Mobile Applications
Patients
Privacy
Self-efficacy
Smartphone
Smartphones
Dieta
stool titration
cirrhosis
artificial intelligence
self-efficacy
Online AccessGet full text
ISSN0002-9270
1572-0241
1572-0241
DOI10.14309/ajg.0000000000002646

Cover

More Information
Summary:Lactulose-based hepatic encephalopathy treatment requires bowel movements/day titration, which is improved with Bristol stool scale (BSS) incorporation. Dieta app evaluates artificial intelligence (AI)-based BSS (AI-BSS) with stool images. Initially, controls (N = 13) and cirrhosis patients on lactulose/not on lactulose (n = 33) were trained on the app. They entered self-reported BSS (self-BSS) with AI-BSS communicated. Lactulose dose changes were tracked. A subset (n = 12) was retested with AI communication blocked. Most subjects were comfortable with the app. Self/AI-BSS and lactulose dose/AI-BSS correlation increased with app use. AI-BSS communications improved insight into self-BSS over time. Dieta app to gauge stool AI characteristics was acceptable and increased insight into lactulose dose and BSS in cirrhosis.
Bibliography:Correspondence: Jasmohan S. Bajaj, MD, FACG. E-mail: jasmohan.bajaj@vcuhealth.org.SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/AJG/D156
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0002-9270
1572-0241
1572-0241
DOI:10.14309/ajg.0000000000002646